Document:

EX-10.4

 Exhibit 10.4 

INDEMNIFICATION AGREEMENT 

INDEMNIFICATION AGREEMENT (“Agreement”), which provides for indemnification, expense advancement and other rights under the
terms and conditions set forth, is made and entered into this [    ] day of November, 2016, between Microbot Medical Inc. (f/k/a StemCells, Inc.; the “Company”), and
[                    ] (“Indemnitee”). 

Recitals 
 WHEREAS,
Indemnitee is serving as a director or an executive officer of the Company, and as such is performing a valuable service for the Company; and 

WHEREAS, the Indemnitee has requested, and the Company has agreed, that Indemnitee is furnished with the indemnity, advancement, and
other rights set forth in this Agreement. 
 Agreement 

NOW, THEREFORE, in consideration of Indemnitee’s service to the Company, the parties hereto agree as follows: 

1. Definitions. For purposes of this Agreement. 

(a) “Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which
indemnification or advancement of expenses is sought by Indemnitee. 
 (b) “Effective Date” means the date first above written.

 (c) “Expenses” include all direct and indirect costs including, but not limited to, reasonable attorneys’ fees and
expenses, judgments, fines, penalties and amounts paid in settlement and all other disbursements or expenses of the types customarily incurred in connection with investigating, prosecuting, defending (or preparing to investigate, prosecute, or
defend) a Proceeding, or being or preparing to be a witness in a Proceeding. 
 (d) “Independent Counsel” means a law firm, or a
member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past two (2) years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party, or
(ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of
professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. 

(e) “Official Capacity” means Indemnitee’s corporate status as an officer or director and any other fiduciary capacity in which
Indemnitee serves the Company, its subsidiaries and affiliates, or any other entity or enterprise (including an employee benefit plan) which Indemnitee serves in such capacity at the request of the Company’s CEO, its Board of Directors or any
committee of its Board of Directors the Company. “Official Capacity” also refers to actions that Indemnitee takes or does not take while serving in such capacity. 

 (f) “Proceeding” includes any actual or threatened inquiry, investigation, action,
suit, arbitration or other proceeding, whether civil, criminal, administrative, or investigative, whether or not initiated prior to the Effective Date, except a proceeding initiated by an Indemnitee pursuant to Section 6 to enforce his or her
rights under this Agreement. “Proceeding” also includes any corporate internal investigation from and after the time in which the Indemnitee has received or is entitled to receive the warning mandated in Upjohn Co. v. United States, 449
U.S. 383 (1981). 
 2. Indemnification. 

(a) General. Except as otherwise provided in this Agreement, the Company shall indemnify Indemnitee to the fullest extent permitted by
the Delaware General Corporation Law (“DGCL”) as such law may from time to time be amended and to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that
increase the extent to which a corporation may indemnify its officers and directors. Indemnitee shall be entitled to the indemnification provided in this Section if, by reason of his or her Official Capacity, Indemnitee is a party or is threatened
to be made a party to any Proceeding or by reason of anything done or not done by Indemnitee in his or her Official Capacity. The Company shall indemnify Indemnitee against all Expenses paid in settlement by or on behalf of Indemnitee in any
Proceeding, and Expenses actually and reasonably incurred by Indemnitee or on his or her behalf in connection with such Proceeding, if Indemnitee is determined to have met the standard of conduct set forth in Section 5(a). 

(b) Exceptions and Limitation. Indemnitee is not entitled to indemnification: 

 

	 	i.	to the extent such indemnification of Expenses is expressly prohibited by Delaware law or the public policies of Delaware, the United States of America, or agencies of any governmental authority in any jurisdiction
governing the matter in question; 

  

	 	ii.	in connection with any Proceeding, or part thereof (including claims and permissive counterclaims) initiated by Indemnitee, except a judicial proceeding pursuant to Section 6 to enforce rights under this Agreement,
unless the Proceeding (or part thereof) was authorized by the Board of Directors of the Company; 

  

	 	iii.	with respect to any claim, issue, or matter as to which Delaware law expressly prohibits such indemnification by reason of any adjudication of liability of Indemnitee to the Company, unless and only to the extent that
the Delaware Court of Chancery, or the court in which such action or suit was brought, determines upon application that, despite an adjudication of liability but in view of all the circumstances of the case, Indemnitee is entitled to indemnification
for such Expenses as such court deems proper. 

  
 2 

 3. Advancement of Expenses. 

(a) General. Except as otherwise provided in this Agreement, the Company shall advance Expenses to Indemnitee to the fullest extent
permitted by the Delaware General Corporation Law as such law may from time to time be amended, and such advancement shall be made as soon as reasonably practicable, but in any event no later than thirty (30) days, after the receipt by the
Company of a written statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding. Indemnitee shall be entitled to the advancement provided in this Section if by reason of his or
her Official Capacity, Indemnitee is a party or is threatened to be made a party to any Proceeding or by reason of anything done or not done by Indemnitee in his or her Official Capacity. The Company shall advance to Indemnitee Expenses actually and
reasonably incurred by Indemnitee in connection with such Proceeding. 
 (b) Undertaking in Connection with Request for Advancement.
As a condition precedent to the Company’s advancement of Expenses to Indemnitee, Indemnitee shall provide the Company with (a) a written claim for Expenses incurred or paid by an Indemnitee in respect of the Proceeding as Indemnitee incurs
them and (b) an undertaking, in substantially the form attached as Exhibit 1, by or on behalf of Indemnitee to reimburse such amount if it is finally determined, after all appeals to a court of competent jurisdiction are exhausted, that
Indemnitee is not entitled to be indemnified against such Expenses by the Company as provided by this Agreement or otherwise. Indemnitee’s undertaking to reimburse any such amounts is not required to be secured. In making a written claim for
advancement, Indemnitee need not submit to the Company information that counsel for Indemnitee deems is privileged and exempt from compulsory disclosure in any proceeding. 

4. Indemnification for Expenses of Successful Party. Notwithstanding the limitations of any other provisions of this Agreement, to the
extent that Indemnitee is successful on the merits or otherwise in defense of any Proceeding, or in defense of any claim, issue or matter therein, including, without limitation, the dismissal of any action without prejudice, or if it is ultimately
determined that Indemnitee is otherwise entitled to be indemnified against Expenses, Indemnitee shall be Indemnified against all Expenses actually and reasonably incurred in connection therewith, including the cancellation of any obligation to repay
advances for expenses incurred in defense of the claim. If Indemnitee is partially successful on the merits or otherwise in defense of any Proceeding, such indemnification shall be apportioned appropriately to reflect the degree of success. 

5. Determination of Entitlement to Indemnification. 

(a) Standard of Conduct. Indemnitee shall be entitled to indemnification pursuant to this Agreement only upon a determination that
Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal action or proceeding, had no reasonable cause to believe that
Indemnitee’s conduct was unlawful. 
 (b) Application for Indemnification. To obtain indemnification, Indemnitee shall submit to
the Company a written request, including therein or therewith such 

  
 3 

 
documentation and information as is reasonably available to Indemnitee and as is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following
the final disposition of the Proceeding. The Company shall, as soon as reasonably practicable after receipt of such a request for indemnification, advise the board of directors that Indemnitee has requested indemnification. Any delay in providing
the request will not relieve the Company from its obligations under this Agreement. 
 (c) Manner of Determining Eligibility. Upon
written request of the Indemnitee for indemnification, the entitlement of Indemnitee to such requested indemnification shall be determined by: 
  

	 	i.	the Board of Directors of the Company by a majority vote of Disinterested Directors, whether or not such majority constitutes a quorum; or 

 

	 	ii.	a committee of Disinterested Directors designated by majority vote of such Disinterested Directors, whether or not such majority constitutes a quorum; or 

 

	 	iii.	if there are no Disinterested Directors or, if such Disinterested Directors so direct, Independent Counsel in a written opinion to the board of directors, or designated committee of the Board, with a copy to Indemnitee,
which Independent Counsel shall be selected by majority vote of the Company’s directors at a meeting at which a quorum is present, or a majority vote of the Disinterested Directors, or Committee of Disinterested Directors; or 

 

	 	iv.	if so directed by the Company’s Board, the Company’s stockholders, by a majority vote of those in attendance at a meeting at which a quorum is present. 

(d) Payment of Costs of Determining Eligibility. The Company shall pay all costs associated with its determination of Indemnitee’s
eligibility for indemnification. 
 (e) Presumptions and Effect of Certain Proceedings. 

 

	 	i.	 In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity
making such determination shall, to the fullest extent not prohibited by law, start with a presumption that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with
Section 5(b) of this Agreement’ provided, however, that such presumption shall not limit the Company from making a determination of eligibility or entitlement to indemnification pursuant to the terms of this Agreement. The
Secretary of the Company shall, promptly upon receipt of Indemnitee’s request for indemnification, advise in writing the Board of Directors or such other person or persons empowered to make the

  
 4 

	 	
determination requested in Section 5(c), and the Company shall thereafter promptly make such determination or initiate the appropriate process for making such determination.

  

	 	ii.	If the determination as to whether Indemnitee is entitled to indemnification shall not have made within sixty (60) days after receipt by the Company of the request therefor, the requisite determination of
entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission
of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law; provided, however, that such
60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional
time for the obtaining or evaluating of documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this Section 5(e)(ii) shall not apply (i) if the determination of entitlement to
indemnification is to be made by the stockholders pursuant to Section 5(c)(iv) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has resolved to submit
such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders is
called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat, or
(ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 5(c)(iii) of this Agreement. 

  

	 	iii.	The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly
provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the
best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee’s conduct was unlawful. 

  
 5 

 6. Remedies of Indemnitee. 

(a) In the event that (i) a determination is made pursuant to Section 5 of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable law, is not timely made pursuant to Section 3, (iii) no determination of entitlement to indemnification shall have been
made pursuant to Section 5(b) or (c) within sixty (60) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Section 4 within fifteen (15) business
days after receipt by the Company of written request therefor, (v) payment of indemnification pursuant to Section 2 is not made within fifteen (15) business days after a determination has been made that Indemnitee is entitled to
indemnification, or (vi) the Company or any other person or entity takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or proceeding designed to deny, or to recover
from, Indemnitee the benefits provided or intended to be provided to Indemnitee hereunder, Indemnitee shall be entitled to seek an adjudication by the Delaware Court of Chancery of Indemnitee’s right to such indemnification or advancement of
Expenses. The Company shall not oppose Indemnitee’s right to seek any such adjudication. 
 (b) In the event that a determination shall
have been made pursuant to Section 5 of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding commenced pursuant to this Section 6, shall be conducted in all respects as a de novo trial on the merits
and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding commenced pursuant to this Section 6, Indemnitee shall be presumed to be entitled to indemnification under this Agreement and the Company
shall have the burden of proving by a preponderance of the evidence that Indemnitee’ has acted in bad faith and in a manner not in the best interests of or opposed to the best interests of the Company, and, in respect of a criminal Proceeding,
by clear and convincing evidence that Indemnitee acted without a reasonable belief that Indemnitee’s conduct was not criminal. The Company may not refer to or introduce into evidence any determination pursuant to Section 5 of this
Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding pursuant to this Section, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 2 until a final
determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). 

(c) Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the
commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or
Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or constitute evidence that Indemnitee has not met the applicable standard of conduct. If a determination shall have been made
pursuant to Section 5 that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section 6, absent (i) a misstatement by Indemnitee of a
material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.

 (d) The Company will be precluded from asserting in any judicial proceeding commenced pursuant to this section that the procedures and
presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the Company is bound by all the provisions of this Agreement. 

  
 6 

 (e) The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by
law and this Agreement against all Expenses and, if requested by Indemnitee, shall (within ten (10) days after the Company’s receipt of such written request) advance to Indemnitee, to the fullest extent permitted by applicable law and this
Agreement, such Expenses that are incurred by Indemnitee in connection with any judicial proceeding brought by Indemnitee to enforce Indemnitee’s rights under, or to recover damages for breach of, this Agreement or any other indemnification
agreement or provision of the Certificate of Incorporation, or the Company’s By-laws now or hereafter in effect. 
 (f) Notwithstanding
anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding as to which advancement or indemnity is sought. 

7. Continuation of Obligation of Company. All agreements and obligations of the Company contained in this Agreement shall continue
during the period of Indemnitee’s Official Capacity and shall continue thereafter with respect to any Proceedings based on or arising out of Indemnitee’s Official Capacity. This Agreement will be binding upon all successors and assigns of
the Company (including any transferee of all or substantially all of its assets and any successor by purchase, merger, consolidation or operation of law). The Company shall require and cause any successor (whether direct or indirect by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company, by written agreement, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would
be required to perform if no such succession had taken place. 
 8. Notification and Defense of Claim. Promptly after receipt by
Indemnitee of notice of any Proceeding, Indemnitee shall notify the Company in writing of the existence thereof; but Indemnitee’s failure so to notify the Company will not relieve the Company from any liability that it may have to Indemnitee.
Notwithstanding any other provision of this Agreement, with respect to any such Proceeding of which Indemnitee notifies the Company: 
 (a)
Except as otherwise provided in this Section 8(a), to the extent that it may wish, the Company may, separately or jointly with any other indemnifying party, assume the defense of the Proceeding. After notice from the Company to Indemnitee of
its election to assume the defense of the Proceeding, the Company shall not be liable to Indemnitee under this Agreement for any Expenses subsequently incurred by Indemnitee except as otherwise provided below. Indemnitee shall have the right to
employ Indemnitee’s own counsel in such Proceeding, but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense thereof shall be at the expense of Indemnitee unless (i) the employment
of counsel by Indemnitee has been authorized by the Company, (ii) Indemnitee shall have reasonably determined that there is a conflict of interest between the Company and Indemnitee in the conduct of the defense of the Proceeding, and such
determination is supported by an opinion of qualified legal counsel addressed to the Company, or (iii) the Company shall not within sixty (60) calendar days of receipt of notice from Indemnitee in fact have employed counsel to assume the
defense of the Proceeding. 

  
 7 

 (b) The Company is not entitled to assume the defense of any Proceeding brought by or on behalf
of the Company, or as to which Indemnitee shall have made the determination provided for in subparagraph (a)(ii) above. 
 (c) Regardless of
whether the Company has assumed the defense of a Proceeding, the Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any Proceeding effected without the Company’s written consent, and
the Company shall not settle any Proceeding in any manner that would impose any penalty or limitation on, or require any payment from, Indemnitee without Indemnitee’s written consent. Neither the Company nor Indemnitee may unreasonably withhold
its consent to any proposed settlement. 
 (d) Until the Company receives notice of a Proceeding from Indemnitee, the Company shall have no
obligation to indemnify or advance Expenses to Indemnitee as to Expenses incurred prior to Indemnitee’s notification of Company. 
 9.
Separability; Prior Indemnification Agreements. 
 (a) If any provision of this Agreement is held to be invalid, illegal, or
unenforceable for any reason whatsoever, (i) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, all portions of any paragraphs of this Agreement containing any such provision
held to be invalid, illegal, or unenforceable, that are not by themselves invalid, illegal or unenforceable) will not in any way be affected or impaired thereby, and (ii) to the fullest extent possible, the provisions of this Agreement
(including, without limitation, all portions of any paragraph of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) are to be construed so as to give
effect to the intent of the parties that the Company provide protection to Indemnitee to the fullest enforceable extent provided for in this Agreement. 

(b) Indemnitee’s rights of indemnification and to receive advancement of Expenses under this Agreement are not exclusive of any other
rights to which Indemnitee may at any time be entitled under applicable law, the Certificate of Incorporation, the Company’s Bylaws, any other agreement, a vote of stockholders or a resolution of directors, or otherwise. The entry by Indemnitee
into this Agreement, and the terms of this Agreement do not, change, limit, or affect in any respect, or terminate, any other agreements between Indemnitee and the Company. 

10. Nonattribution of Actions of Any Indemnitee to Any Other Indemnitee. For purposes of determining whether Indemnitee is entitled to
indemnification or advancement of Expenses by the Company under this Agreement or otherwise, no action or inaction of any other indemnitee or group of indemnitees may be attributed to Indemnitee. 

11. Insurance. In all policies of director and officer liability insurance purchased by Company, the Company shall cause Indemnitee to
be named as an insured in such a manner as to provide Indemnitee the same rights and benefits as are accorded to the most favorably insured of 

  
 8 

 
the Company’s officers and directors (other than in the case of an independent director liability insurance policy if Indemnitee is not an independent or outside director). Company shall
promptly notify Indemnitee of any good faith determination not to provide such coverage or of any lapse or termination of any such policy. 

12. Headings; References; Pronouns. The headings of the sections of this Agreement are inserted for convenience only; they do not
constitute part of this Agreement or affect the meaning thereof. References herein to section numbers are to sections of this Agreement. All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular,
or plural as appropriate. 
 13. Other Provisions. 

(a) This Agreement shall be interpreted and enforced in accordance with the laws of Delaware. 

(b) This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of
which together shall constitute one and the same Agreement. Signatures delivered by facsimile or other electronic means shall be deemed as an original. 

(c) This Agreement is not an employment agreement between the Company and Indemnitee, and nothing in this Agreement obligates the Company to
continue Indemnitee in Indemnitee’s Official Capacity. 
 (d) Upon a payment to Indemnitee under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of Indemnitee to recover against any person for such liability, and Indemnitee shall execute all documents and instruments required and shall take such other actions as may be necessary
to secure such rights, including the execution of such documents as may be necessary for the Company to bring suit to enforce such rights. 

(e) No supplement, modification, or amendment of this Agreement will be binding unless executed in writing signed by both parties hereto. No
waiver of any of the provision of this Agreement shall be deemed or shall constitute a waiver of any other provision hereof (whether or not similar). A waiver made in a signed writing on one occasion is effective only in that instance and does not
constitute a waiver on any future occasion or instance. 
 (f) The Company agrees to stipulate in any court or before any arbitrator that
the Company is bound by all the provisions of this Agreement and is precluded from making any assertions to the contrary. 
 (g)
Indemnitee’s rights under this Agreement shall extend to Indemnitee’s spouse, members of Indemnitee’s immediate family, and Indemnitee’s representative(s), guardian(s), conservator(s), estate, executor(s), administrator(s), and
trustee(s), (all of whom are referred to as “Related Parties”), as the case may be, to the extent a Related Party or a Related Party’s property is subject to a Proceeding by reason of Indemnitee’s Official Capacity. 

  
 9 

 (h) To the extent that Indemnitee (i) pays Expenses that the Company is obligated to but
does not advance, or (ii) incurs expense, liability, or loss for which the Company is obligated to indemnify Indemnitee, Indemnitee will be subrogated to the Company’s rights of recovery against any insurance carrier or other source to the
same extent as if the Company had paid such Expense, liability, or loss or advanced such expense under this Agreement. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK;
SIGNATURE PAGE FOLLOWS] 

  
 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day
and year first above written. 
  

			
	MICROBOT MEDICAL INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	  

	[Indemnitee]

  
 11 

 EXHIBIT 1 

UNDERTAKING TO REPAY INDEMNIFICATION EXPENSES 

I [                    ], agree to reimburse the
Company for all expenses advanced to me or for my benefit by the Company for my defense in any civil or criminal action, suit, or Proceeding, in the event and to the extent that it shall ultimately be determined that I am not entitled to be
indemnified by the Company for such expenses. 
  

			
	Signature:	 	  

 
			
		
	Typed Name:	 	  

 
			
		
	Office:	 	  

  
 12EX-10.5

 Exhibit 10.5 

EMPLOYMENT AGREEMENT 

EMPLOYMENT AGREEMENT (the “Agreement”), effective as of November 28, 2016 (the “Effective Date”), by and between
Microbot Medical, Inc. (formerly known as StemCells, Inc.), a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Harel Gadot (the “Executive”). 

WITNESSETH: 
 WHEREAS,
pursuant to the Consulting Agreement, dated March 7, 2011 (the “Consulting Agreement”), between Microbot Medical Ltd., an Israeli corporation (“Microbot Israel”), and MEDX Ventures Group LLC (“MEDX”), the
Executive, through MEDX, provides services to Microbot Israel; and 
 WHEREAS, on the Effective Date, Microbot Israel consummated a
transaction whereby, among other things, a wholly-owned subsidiary of the Company merged with and into Microbot Israel, with Microbot Israel as the surviving entity and a wholly-owned subsidiary of the Company (the “Merger Transaction”);
and 
 WHEREAS, (a) Microbot Israel, MEDX and the Executive wish to terminate the Consulting Agreement and (b) the Company and the
Executive wish to enter into a direct employment relationship in replacement thereof; and 
 WHEREAS, the Company is desirous of securing
the Executive’s continued services and Executive is willing to provide such services, upon the terms and subject to the conditions hereinafter set forth. 

NOW, THEREFORE, for and in consideration of the mutual covenants contained herein, the parties hereto agree as follows: 

1. EMPLOYMENT OF EXECUTIVE. The Company hereby employs the Executive, and the Executive hereby accepts said employment, all pursuant to
the terms and conditions of this Agreement. 
 2. DUTIES. The Executive shall render, as an employee, professional services as the
Chairman of the Board of Directors (the “Board”) and Chief Executive Officer of the Company, shall perform such additional duties consistent with being a Chairman of the Board of Directors and chief executive officer of a public
corporation and as may be assigned to the Executive by the Board from time to time, and shall comply with such reasonable policies, standards and regulations of the Company as are from time to time established by the Board (collectively,
“Duties”). The Executive agrees to devote such time and effort to the performance of his Duties as the Executive deems necessary and reasonable, except for customary vacations and reasonable absences due to illness or other incapacity as
set forth herein, and to perform all of his Duties to the best of his professional ability. Nothing contained herein shall be construed so as to prohibit or prevent the Executive from engaging in charitable causes, sitting on the boards of directors
or as chairman of other entities, or managing his and his family’s personal 

 
finances. Provided that the Company has a replacement for the chief executive officer position, during the period ending on the two (2) year anniversary of this Agreement, Executive shall
have the option to resign as chief executive officer of the Company (but not as Chairman) and instead be appointed President of the Company with such duties and powers as are commonly incident to the office of the president (but not as chief
executive officer of the Company) of a public company and such additional duties and powers as the Board may from time to time designate (in either case, the “Position”). For so long as the Executive is in the Position, the Company shall
nominate the Executive to the Board and for so long as the Executive is a Board member, shall be Chairman of the Board. 
 3. TERM.
The Executive shall be employed until terminated pursuant to the termination provisions set out in Section 12 of this Agreement (the “Term”). 

4. PLACE OF EMPLOYMENT. The Company shall provide the Executive with an executive office no greater then twenty-five (25) miles
from Executive’s primary residence (the “Residence”), which is currently located at Hingham, Massachusetts. Notwithstanding the foregoing, the Executive understands and agrees that the Position requires travel from time to time on
behalf of the Company, including to the Company’s offices in Israel, to fulfill the Duties. 
 5. COMPENSATION. For all services
rendered to the Company, the Company shall provide Executive as total compensation a sum computed as set forth in this Section 5. 

(a) Base Salary. The Company shall pay the Executive a base salary at the rate of Three Hundred Sixty Thousand Dollars ($360,000.00)
per year (the “Base Salary”) in accordance with the customary payroll practices of the Company applicable to senior executives. During the Term, the compensation committee of the Board, or, if there be no such compensation committee, the
entire Board other than the Executive (in either case, the “Compensation Committee”), shall review the Executive’s Base Salary on an annual basis and may provide for such increases thereto as it may determine, taking into account such
performance metrics and criteria of the Executive and of the Company in the Compensation Committee’s sole discretion. 
 (b)
Automobile Allowance. During the Term, Executive shall receive an automobile allowance in the amount of Seven Hundred Dollars ($700) plus an additional Four Hundred Fifty Dollars ($450) for automobile-related expenses and a tax gross-up per
month. 
 (c) Discretionary Annual Bonuses. For each calendar year during the Term, Executive shall be eligible to receive a bonus
(the “Target Bonus”) up to a maximum amount of forty percent (40%) of his Base Salary for performance at the maximum level; provided, however, that Executive must be employed in the Position as of December 31st of the year to
which the Target Bonus relates in order to be paid the Target Bonus. The calculation of the Target Bonus shall be based upon corporate performance factors established and assessed by the Compensation Committee that will take into account the
performance of Executive based on the achievement of Executive’s objectives agreed to with the Compensation Committee for a particular year. The Target Bonus shall be paid in a lump sum cash payment as soon as reasonably practicable following
December 31st of the year to which the Target Bonus relates. Upon the closing of the Merger Transaction, the Executive shall be paid a one-time bonus of Fifty Thousand Dollars ($50,000). 

  
 2 

 (d) CEO Option Grant. As soon as reasonably practicable following the Effective Date, the
Company shall grant to the Executive options to purchase shares of the common stock of the Company, representing five percent (5%) of the issued and outstanding shares of the Company as of the closing and the Merger Transaction (the “CEO
Option Grant”), subject to tax, Section 409A and Section 162(m) considerations and limitations set forth in the incentive plan governing the CEO Option Grant, it being understood that in the event any such limitations would cause the
number of options provided for in this Section 5(d) to be reduced, the Company and the Executive shall determine in good faith a reasonable alternative or substitute so that the Executive receives as closely as possible the CEO Option Grant as
provided herein. The Company shall deliver an award agreement to Executive that sets forth the terms and conditions of the CEO Option Grant (the “CEO Award Agreement”), based on the recommendations and approval of the Compensation
Committee of the Board, including vesting and term. 
 6. VACATION/SICK TIME. The Executive shall be entitled to vacation time in
accordance with the Company’s policies in effect from time to time, with full pay, of five (5) weeks twenty-five (25) working days), during each year of Executive’s employment. The scheduling of any vacation shall be coordinated
with the Company so that the staffing needs of the Company are met to the extent reasonable possible. The Executive may accumulate up to one (1) year of unused vacation time; any unused vacation time above such limit, as shall be calculated at
the end of each calendar year, shall be forfeited, subject to applicable law. The Executive shall be granted sick time in accordance with the Company’s policy in effect from time to time. 

7. REIMBURSEMENT OF BUSINESS EXPENSES. The Company shall reimburse Executive for expenses reasonably incurred during the course of
Executive’s employment. Such reimbursement shall be made in accordance with Company policies in effect from time to time upon presentation of receipts and such other additional substantiation and justification satisfactory to the Company for
expenses actually incurred in connection with the foregoing. 
 8. ADDITIONAL BENEFITS. The Executive shall be eligible to
participate in the Company’s benefits plans available to its employees from time to time in accordance with the terms and conditions of such plans. The Company reserves the right to alter, amend, replace or discontinue the benefit plans it
makes available to its employees (including the Executive), at any time, with or without notice. 
 9. COMPANY PROPERTY DEFINED. The
Executive acknowledges and understands that Company files, customer files, legal files, legal research files, form files, forms, examples, samples, and all briefs and memoranda, intellectual property and other work product or property, and all
copies thereof (the “Company Property”) are the sole and exclusive property of the Company; and the Company Property shall remain in the possession of the Company and shall constitute the property of the Company irrespective of who
prepared the Company 

  
 3 

 
Property. The Executive shall not remove, photocopy, photograph or in any other manner duplicate or remove said Company Property other than in the performance of his Duties for or on behalf of
the Company. The provisions of this Section 9 shall survive the termination of this Agreement and the Executive’s employment with the Company. 

10. DISPOSITION OF PROPERTY UPON TERMINATION OF EMPLOYMENT. In the event the employment of the Executive with the Company is
terminated, the Executive shall promptly return to the Company all Company Property in his possession or control, and the Executive shall have no right, title or interest in the same. The provisions of this Section 10 shall survive the
termination of this Agreement and the Executive’s employment with the Company. 
 11. OWNERSHIP OF PATENTS AND INTELLECTUAL
PROPERTY. Any work prepared for the Company during the course of the Executive’s employment by the Company that is eligible for copyright, patent and/or trademark protection under the laws of the United States or any other country and any
proprietary know-how developed by Executive while rendering services for the Company will vest in the Company. Executive hereby grants, transfers and assigns all right, title and interest in such work and all copyrights, patents and trademarks in
such work and all renewals and extensions thereof to the Company, all of which shall be deemed a work for hire for the Company under the U.S. Copyright Act to the fullest extent permitted under the law, and Executive shall provide all assistance
reasonably requested by the Company in the establishment, preservation and enforcement of the Company’s copyright, patents and trademarks in such work, such assistance to be provided at the Company’s expense but without any additional
compensation to Executive. If the Company cannot, after reasonable effort, secure Executive’s signature on any documents needed to apply for or prosecute any patent, copyright, trademark or other right or protection relating to an invention,
whether because of Executive’s physical or mental incapacity or for any other reason whatsoever, Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Executive’s agent and
attorney-in-fact, to act for and on Executive’s behalf and in Executive’s name and stead for the purpose of executing and filing any such application or applications and taking all other lawfully permitted actions to further the
prosecution and issuance of patents, copyrights, trademarks or similar protections thereon, with the same legal force and effect as if executed by Executive. The provisions of this Section 11 shall survive the termination of this Agreement and
the Executive’s employment with the Company. 
 12. TERMINATION OF EMPLOYMENT. The employment of the Executive may be terminated
as follows: 
 (a) Termination on Notice. Subject to the remaining clauses of this Section 12, either party shall have the right
to terminate Executive’s employment under this Agreement at any time for any reason or no reason upon two (2) months prior written notice. In the event that the Company or Executive gives notice to terminate pursuant to the foregoing
sentence, the Company may elect to have Executive cease working immediately so long as the Company continues to pay Executive’s Base Salary in accordance with the provisions of Section (5)(a) for the entire two (2) month notice period
(such payment, the “Continuation Pay”). In the event the Company elects to have Executive immediately cease working during the two (2) month notice period as provided in the foregoing sentence and Executive finds alternative
employment that is 

  
 4 

 
not in violation of any provision herein, including, without limitation, Section 13 hereof, Executive may accept and engage in the alternative employment without forfeiting the Continuation
Pay. 
 (b) Termination by the Company for Cause. The Company may terminate this Agreement and the Executive’s employment
hereunder for Cause (as defined below), effective upon delivery of written notice (the “Termination Notice”) to the Executive given at any time during the Term. For purposes of this Agreement, “Cause” shall mean the
Executive’s: (i) conviction of any felony or any other crime involving dishonesty or moral turpitude; (ii) commission of any act of fraud or dishonesty, or theft of or maliciously intentional damage to the property of the Company or
any of its subsidiaries or affiliates; (iii) willful or intentional breach of his fiduciary duties to the Company; or (iv) breach of any material provision of this Agreement. Notwithstanding the foregoing, prior to any termination by the
Company of the Executive’s employment for Cause, the Executive shall first have an opportunity to cure or remedy such act of default within ten (10) days following the Termination Notice, or if the remedy cannot reasonably be cured or
remedied within such ten (10) day period but can reasonably be cured or remedied within forty five (45) days following the Termination Notice, the Executive may cure or remedy such act of default with forty five (45) days provided
that the Executive diligently pursues such cure or remedy promptly following the Termination Notice, and in either such case such Termination Notice shall then become null and void. 

(c) Termination by the Executive for Good Reason. The Executive may terminate this Agreement and Executive’s employment hereunder
with Good Reason (as defined below) effective upon delivery of a Termination Notice to the Company given at any time during the Term. For purposes of this Agreement, “Good Reason” shall mean: (i) the material reduction of the
Executive’s title (other than as specifically provided in Section 2), authority, duties and responsibilities or the assignment to the Executive of duties materially inconsistent with the Executive’s Position at that time;
(ii) any reduction in Base Salary of the Executive; or (iii) breach of any material provision of this Agreement by the Company. Notwithstanding the foregoing, prior to any termination by the Executive of the Executive’s employment for
Good Reason, the Company shall first have an opportunity to cure or remedy such act of default within ten (10) days following the Termination Notice, or if the remedy cannot reasonably be cured or remedied within such ten (10) day period
but can reasonably be cured or remedied within forty five (45) days following the Termination Notice, the Company may cure or remedy such act of default with forty five (45) days provided that the Company diligently pursues such cure or
remedy promptly following the Termination Notice, and in either such case such Termination Notice shall then become null and void. 
 (d)
Termination by Death. If the Executive dies while employed under this Agreement, this Agreement shall terminate immediately and the Company shall pay to the Executive’s estate any earned Base Salary, Target Bonus, reimbursement of
business expenses and accrued vacation, if any, that is unpaid up to the date of his death. 
 (e) Termination by Disability. The
Company may terminate this Agreement as a result of any mental or physical disability or illness which results in (a) the Executive being unable to substantially perform his duties for a continuous period of 150 days or for periods aggregating
180 days within any period of 365 days or (b) the Executive being subject to a 

  
 5 

 
permanent or indefinite inability to perform essential functions based on the reasonable opinion of a qualified medical provider chosen in good faith by the Company. Termination will be effective
on the date designated by the Company, and the Executive will be paid his annual Base Salary, Target Bonus, reimbursement of business expenses, accrued vacation, if any, and benefits as set out in Section 8 through the date of termination. 

(f) Payment upon Termination for Cause or without Good Reason. Upon Executive’s termination of employment for Cause, or if
Executive shall terminate without Good Reason, Executive shall forfeit the right to receive any and all further payments hereunder, other than the right to receive any compensation then due and payable to the Executive pursuant to Section 5
hereof through to the date of termination. 
 (g) Payment Upon Termination without Cause or for Good Reason. In the event of the
termination of the Executive’s employment by the Company without Cause or upon the Executive’s voluntary termination of his employment for Good Reason, (i) all amounts of Base Salary accrued but unpaid as of the termination date shall
be paid by the Company within thirty (30) days following the date of termination, (ii) an amount equal to the Executive’s Base Salary on the date of termination for a period of twelve (12) months shall be paid by the Company in
twelve (12) equal monthly installments, (iii) 100% of any such unvested portion of the CEO Option Grant shall immediately vest and become exercisable and shall remain exercisable for the periods specified in each such option; (iv) a
pro rata bonus equal to the maximum Target Bonus for that calendar year; (v) the dollar value of unused and accrued vacation days; and (vi) applicable premiums (inclusive of premiums for Executive’s dependents) shall be paid by the
Company pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended, for twelve (12) months from the date of termination for any benefits plan sponsored by the Company. 

(h) Deferred Compensation. This Agreement is intended to comply with or be exempt from Section 409A of the Internal Revenue Code
of 1986, as amended (the “Code”) and will be interpreted, administered and operated in a manner consistent with that intent. Notwithstanding anything herein to the contrary, if at the time of the Executive’s separation from service
with the Company he is a “specified employee” as defined in Section 409A of the Code (and the regulations thereunder) and any payments or benefits otherwise payable hereunder as a result of such separation from service are subject to
Section 409A of the Code, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to the Executive) until the date
that is six months following the Executive’s separation from service with the Company (or the earliest date as is permitted under Section 409A of the Code), and the Company will pay any such delayed amounts in a lump sum at such time. If
any other payments of money or other benefits due to the Executive hereunder could cause the application of an accelerated or additional tax under Section 409A of the Code, such payments or other benefits shall be deferred if deferral will make
such payment or other benefits compliant under Section 409A of the Code, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that does not cause such an accelerated
or additional tax. To the extent any reimbursements or in-kind benefits due to the Executive under this Agreement constitute “deferred compensation” under Section 409A of the Code, any such reimbursements or in-kind benefits shall be
paid to the Executive in a manner consistent with 

  
 6 

 
Treas. Reg. Section 1.409A-3(i)(1)(iv). Each payment made under this Agreement shall be designated as a “separate payment” within the meaning of Section 409A of the Code.
References to “termination of employment” and similar terms used in this Agreement are intended to refer to “separation from service” within the meaning of Section 409A of the Code to the extent necessary to comply with
Section 409A of the Code. Whenever a payment under this Agreement may be paid within a specified period, the actual date of payment within the specified period shall be within the sole discretion of the Company. In no event may the Executive,
directly or indirectly, designate the calendar year of any payment to be made under this Agreement. Any provision in this Agreement providing for any right of offset or set-off by the Company shall not permit any offset or set-off against payments
of “non-qualified deferred compensation” for purposes of Section 409A of the Code or other amounts or payments to the extent that such offset or set-off would result in any violation of Section 409A or adverse tax consequences to
the Executive under Section 409A. 
 (i) Parachute Payments. In the event that the severance and other benefits provided to the
Executive pursuant to this Agreement (A) constitute “parachute payments” within the meaning of Section 280G of the Code and (B) but for this Section 12, such severance and benefits would be subject to the excise tax
imposed by Section 4999 of the Code, then the Executive’s severance benefits under this Section shall be payable either: (y) in full, or (z) as to such lesser amount which would result in no portion of such severance and other
benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the
receipt by the Executive on an after-tax basis, of the greatest amount of severance benefits under this Agreement. Unless the Company and the Executive otherwise agree in writing, any determination required under this Section 12(i) shall be
made in writing by independent public accountants reasonably agreed to by the Company and the Executive (the “Accountants”), whose determination shall be conclusive and binding upon the Executive and the Company for all purposes. For
purposes of making the calculations required by this Section 12(i), the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application
of Section 280G and 4999 of the Code. The Company and the Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company shall
bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 12(i). 
 13.
RESTRICTIVE COVENANTS. 
 (a) Noncompetition. During the Term and for the twelve (12) month period immediately following
the termination of employment, regardless of the reason for such termination and regardless whether this Agreement has terminated or expired (the “Restricted Period”), he shall not, directly or indirectly: (i) engage in, manage,
operate, control, supervise, or participate in the management, operation, control or supervision of any company or entity that competes with any business of the Company or any of its subsidiaries (a “Competitor”, as further defined below)
or serve as an employee, consultant or in any other capacity for a Competitor; (ii) have any ownership or financial interest, directly, or indirectly, in any Competitor including, without limitation, as an individual, partner, shareholder
(other than as a shareholder of a 

  
 7 

 
publicly-owned corporation in which the Executive owns less than five percent (5%) of the outstanding shares of such corporation), officer, director, employee, principal, agent or
consultant; or (iii) serve as a representative of any Competitor. For the purposes of this Agreement, “Competitor” shall further mean any company or entity, whether located in the United States, the State of Israel or elsewhere, that
engages in the research, design, or development of: (i) shunts for the treatment of hydrocephalus and Normal Pressure Hydrocephalus; or (ii) self-propelling, semi-disposable endoscopes for use in colonoscopy procedures. 

(b) Non-Solicitation; No-Hire. Executive acknowledges and agrees that during the Restricted Period he shall not, directly or
indirectly, other than in connection with carrying out his duties hereunder, (i) solicit or induce any employee or consultant of the Company (or any individual who was an employee or consultant of the Company at any time during the 12-month
period preceding any such solicitation or inducement) to (A) terminate his or her employment or relationship with the Company, and/or (B) work for the Executive or any Competitor, or (ii) hire, or be involved in the process of any
business, entity or division in hiring, any employee or consultant of the Company (or any individual who was an employee or consultant of the Company at any time during the 12-month period preceding any such hiring). 

(c) Non-Solicitation of Clients. Executive acknowledges and agrees that during the Restricted Period he shall not, directly or
indirectly, solicit, take away or divert, or attempt to solicit, take away or divert, the business or patronage of any client or customer of the Company with the intention or for the purpose of providing services that compete with the services
provided by the Company at the time of Executive’s termination. 
 (d) Disparaging Comments. Executive agrees not to make
critical, negative or disparaging remarks about the Company or its management, business or employment practices; provided that nothing in this Section 13(d) shall be deemed to prevent the Executive from responding fully and accurately to any
question, inquiry or request for information when required by applicable law or legal process, or to enforce this Agreement. The Company and its officers and directors shall not make critical, negative or disparaging remarks about the Executive;
provided that nothing in this Section 13(d) shall be deemed to prevent the Company or its officers or directors from (i) responding fully and accurately to any question, inquiry or request for information when required by applicable law or
legal process, (ii) complying with the disclosure requirements under the federal securities laws or any applicable stock exchange or quotation system, or (iii) to enforce this Agreement. 

(e) Confidentiality. The Executive acknowledges and agrees that the Company’s business is highly competitive and that the
Executive will be involved in and become aware of the Company’s trade secrets, materials, know-how (whether or not in writing), technology, product information and intellectual property belonging to the Company (“Trade Secrets”) and
all confidential matters (whether available in written, electronic form or orally) relating to the Company and its business (including without limitation its strategies, models, business and marketing plans, pricing, sales and revenue information,
financial performance, etc.), and personal and other confidential information relating to its owners, directors, officers, investors, shareholders, executives and employees (the “Confidential Information”), all of which

  
 8 

 
have been developed at great investment of time and resources by the Company so as to engender substantial good will, and all of which are and will remain the exclusive property of the Company.
Therefore, the Executive agrees that during the period of his employment with the Company and at all times thereafter, Executive shall not disclose, shall keep secret, shall retain in strictest confidence and shall not use for his benefit or the
benefit of others, except in connection with the business and affairs of the Company, any Trade Secret or Confidential Information. 
 (f)
Acknowledgement. Executive agrees and acknowledges that each restrictive covenant in this Section 13 is reasonable as to duration, terms and geographical area and that the same protects the legitimate interests of the Company, imposes no
undue hardship on Executive, and is not injurious to the public. 
 (g) Survival. All of the restrictive covenants contained in this
Section 13 shall be binding on the assigns, executors, administrators and other legal representatives of the Executive, and shall survive the termination of this Agreement and Executive’s employment. 

14. INJUNCTIVE RELIEF. The Executive acknowledges that the precise value of the covenants in Section 13 are difficult to evaluate
and that no accurate measure of liquidated damages could possibly be established and therefore, in the event of a breach or threatened breach of such provisions, the Company shall be entitled to temporary and permanent injunctive relief (without the
position of a bond or other security) restraining Executive from such breach or threatened breach. Notwithstanding anything to the contrary herein, if any applicable law or governmental entity shall reduce the time period or scope during which the
Executive shall be prohibited from engaging in any competitive or soliciting activity described in Section 13, the period of time or scope, as the case may be, for which the Executive shall be prohibited shall be reduced to the maximum time or
scope permitted by law. 
 15. NOTICES. Any notice required or permitted to be given pursuant to the provisions of this Agreement
shall be sufficient if in writing, and if personally delivered to the party to be notified or if sent by registered or certified mail to said party at the following addresses: 

 

			
	If to the Company:	  	Microbot Medical Inc.
		  	5 Hamada Street
		  	Yokneam 20692, Israel
		  	Attn: Board of Directors
		
	With a copy to:	  	Ruskin Moscou Faltischek, P.C.
		  	1425 RXR Plaza
		  	East Tower, 15th Floor
		  	Uniondale, New York 11556
		  	Attn: Stephen E. Fox, Esq.
		
	If to the Executive:	  	Harel Gadot
		  	5 Village Lane
		  	Hingham, Massachusetts 02043

  
 9 

 16. SEVERABILITY. In the event any portion of this Agreement is held to be invalid or
unenforceable, the invalid or unenforceable portion or provision shall not affect any other provision hereof and this Agreement shall be construed and enforced as if the invalid provision had not been included. 

17. BINDING EFFECT. This Agreement shall inure to the benefit of and shall be binding upon the Company and upon any person, firm or
entity with which the Company may be merged or consolidated or which may acquire all or substantially all of the Company’s assets through sale, lease, liquidation or otherwise. The rights and benefits of Executive are personal to him and no
such rights or benefits shall be subject to assignment or transfer by Executive. 
 18. GOVERNING LAW, VENUE, INTERPRETATION OF
LANGUAGE. The parties agree that this Agreement shall be governed by the laws of the State of Massachusetts, without regard to conflict of laws principles, and that venue for any action between the parties that arises out of this Agreement shall
be in Suffolk County, State of Massachusetts. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement. 
 19. AMENDMENT AND MODIFICATION.
All terms, conditions and provisions of this Agreement shall remain in full force and effect unless modified, changed, altered or amended, in writing, executed by both parties. 

20. INDEPENDENT LEGAL ADVICE. The Executive acknowledges that he has been advised to seek independent legal counsel in respect of the
Agreement and the matters contemplated herein. To the extent that he declines to receive independent legal counsel in respect of the Agreement, he waives the right, should a dispute later develop, to rely on his lack of independent legal counsel to
avoid his obligations, to seek indulgences from the Company or to otherwise attack the integrity of the Agreement and the provisions thereof, in whole or in part. 

21. COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original as
against any party whose signature appears thereon, and all of which shall together constitute one and the same instrument. This Agreement shall become binding when one or more counterparts hereof, individually or taken together, shall bear the
signatures of all of the parties reflected hereon as the signatories. Delivery of an executed counterpart of this Agreement electronically or by facsimile shall be effective as delivery of an original executed counterpart of this Agreement. 

22. ENTIRE AGREEMENT. This Agreement constitutes the entire agreement between the parties and supersedes and replaces any prior
agreement, including but not limited to the Consulting Agreement, which for all purposes shall be deemed terminated and of no further force and effect; and there are no other agreements between the parties with respect to the subject matter
contained herein except as set forth herein. 
 [Signatures follow on next page] 

  
 10 

 IN WITNESS WHEREOF, the parties hereto have set their hands and seals effective on the day and
year first above written. 
  

			
	Microbot Medical, Inc.
	
	 /s/ David Ben Naim

	Name:	 	David Ben Naim
	Title:	 	CFO
	
	 /s/ Harel Gadot

	Harel Gadot
	
	Solely for purposes of Section 22:
	
	MEDX Ventures Group LLC
		
	By:	 	 /s/ Harel Gadot

	Name:	 	Harel Gadot
	Title:	 	
	
	Microbot Medical Ltd.
		
	By:	 	 /s/ Harel Gadot

	Name:	 	Harel Gadot
	Title:	 	Chairman and Chief Executive Officer

  
 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]